Table 32 (Abstract P301). See text for description
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part two
Year | N of Total Children | Diagnosis Code for Systemic Sclerosis | No Diagnosis Code for Localized Scleroderma | Use of Methotrexate, Mycophenolate Mofetil, or Cyclophosphamide | Estimated Prevalence per 1,000,000 Children [95% CI] |
|---|---|---|---|---|---|
2010 | 5,888,868 | 254 | 186 | 23 | 3.9 [2.5-5.9] |
2011 | 6,231,475 | 249 | 185 | 22 | 3.5 [2.2-5.3] |
2012 | 6,278,116 | 217 | 170 | 26 | 4.1 [2.7-6.1] |
2013 | 4,950,018 | 175 | 120 | 17 | 3.4 [2.0-5.5] |
2014 | 4,933,522 | 138 | 91 | 14 | 2.8 [1.6-4.8] |